Education
About Us
Working with TipRanks
Follow Us
Petlife Pharmaceuticals Inc (PTLF)
OTHER OTC:PTLF
PTLF Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume14.65K
Average Volume (3M)357.00
Market Cap
$22.21K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)401.69K
Price to Earnings (P/E)―
Beta43.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding222,120,650
10 Day Avg. Volume320
30 Day Avg. Volume357
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
PTLF FAQ
What was Petlife Pharmaceuticals Inc’s price range in the past 12 months?
Petlife Pharmaceuticals Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Petlife Pharmaceuticals Inc’s market cap?
Petlife Pharmaceuticals Inc’s market cap is $22.21K.
When is Petlife Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Petlife Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Petlife Pharmaceuticals Inc overvalued?
According to Wall Street analysts Petlife Pharmaceuticals Inc’s price is currently Overvalued.
Does Petlife Pharmaceuticals Inc pay dividends?
Petlife Pharmaceuticals Inc does not currently pay dividends.
What is Petlife Pharmaceuticals Inc’s EPS estimate?
Petlife Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Petlife Pharmaceuticals Inc have?
Petlife Pharmaceuticals Inc has 222,120,650 shares outstanding.
What happened to Petlife Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Petlife Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in PTLF
---
Company Description
Petlife Pharmaceuticals Inc
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.
---
Technical Analysis
Salarius Pharmaceuticals
―
Jaguar Animal Health
―
Hepion Pharmaceuticals
―
Petros Pharmaceuticals
―
Virpax Pharmaceuticals
―
---